ProfileGDS4718 / 220680_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 4% 5% 6% 6% 10% 14% 13% 5% 4% 5% 2% 17% 15% 10% 13% 8% 10% 11% 11% 7% 5% 8% 2% 10% 6% 9% 7% 8% 7% 8% 13% 10% 8% 8% 12% 3% 12% 8% 12% 7% 9% 14% 9% 3% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.570894
GSM549102patient 115, normal, homogenized [OPG study]3.587695
GSM549104patient 119, normal, homogenized [OPG study]3.61126
GSM549108patient 138, normal, homogenized [OPG study]3.641096
GSM549119patient 077, normal, homogenized [OPG study]3.7822210
GSM549133patient 032, cancer, homogenized [OPG study]3.8882514
GSM549139patient 042, cancer, homogenized [OPG study]3.8555913
GSM549099patient 107, normal, homogenized [OPG study]3.584825
GSM549109patient 139, normal, homogenized [OPG study]3.550574
GSM549110patient 046, normal, homogenized [OPG study]3.604225
GSM549114patient 063, normal, homogenized [OPG study]3.448212
GSM549122patient 082, normal, homogenized [OPG study]4.0516617
GSM549134patient 033, cancer, homogenized [OPG study]3.9498615
GSM549136patient 036, cancer, homogenized [OPG study]3.7520710
GSM549140patient 044, cancer, homogenized [OPG study]3.8610713
GSM549111patient 047, normal, homogenized [OPG study]3.674928
GSM549113patient 057, normal, homogenized [OPG study]3.7507410
GSM549132patient 031, cancer, homogenized [OPG study]3.8129411
GSM549137patient 038, cancer, homogenized [OPG study]3.8300811
GSM549142patient 047, cancer, homogenized [OPG study]3.732617
GSM549100patient 110, normal, homogenized [OPG study]3.597735
GSM549107patient 135, normal, homogenized [OPG study]3.698038
GSM549115patient 068, normal, homogenized [OPG study]3.41362
GSM549116patient 072, normal, homogenized [OPG study]3.7592510
GSM549120patient 078, normal, homogenized [OPG study]3.629716
GSM549131patient 030, cancer, homogenized [OPG study]3.706229
GSM549118patient 074, normal, homogenized [OPG study]3.678787
GSM549129patient 027, cancer, homogenized [OPG study]3.717838
GSM549123patient 088, normal, homogenized [OPG study]3.683237
GSM549124patient 006, cancer, homogenized [OPG study]3.723578
GSM549126patient 015, cancer, homogenized [OPG study]3.858313
GSM549128patient 025, cancer, homogenized [OPG study]3.7479110
GSM549103patient 117, normal, homogenized [OPG study]3.73278
GSM549117patient 073, normal, homogenized [OPG study]3.702828
GSM549138patient 041, cancer, homogenized [OPG study]3.8236512
GSM549141patient 045, cancer, homogenized [OPG study]3.435113
GSM549130patient 028, cancer, homogenized [OPG study]3.8728212
GSM549101patient 111, normal, homogenized [OPG study]3.681428
GSM549105patient 128, normal, homogenized [OPG study]3.864612
GSM549106patient 134, normal, homogenized [OPG study]3.612347
GSM549112patient 048, normal, homogenized [OPG study]3.759789
GSM549125patient 011, cancer, homogenized [OPG study]3.9358214
GSM549127patient 024, cancer, homogenized [OPG study]3.715869
GSM549135patient 035, cancer, homogenized [OPG study]3.469593